UniQure stock drops on new Huntington's drug data

The gene therapy developer said it's encouraged by the data, however, pointing to several positive signals from the Phase 1/2 trial.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 21, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news